Silicon Valley Bank, established in 1983, is a leading commercial bank headquartered in Santa Clara, California. It specializes in providing a wide array of financial services, including banking, treasury management, and international banking, to innovative technology, life science, and premium wine businesses, as well as venture capital and private equity firms. With a global presence through 27 U.S. offices and seven international operations, the bank leverages its industry knowledge, connections, and world-class service to support the success of its clients.
Managing Director of National Healthcare Sponsor Finance and Life Sciences
Matt Garrity
Senior Vice President
Rob Helm
Managing Director
Dale Kirkland
Managing Director - Origination / Relationship Management
Scott McCarty
Director, Life Sciences
Andrew Merget
Managing Director
Christopher Morrison
Managing Director and Head of Boston Enterprise Software
Andrew Oddo
Managing Director, Startup Banking
Andrew Parker
Director
Joan Parsons
Executive Vice President, Corporate Banking
Sameer Paul
Director
Marisa Phan
Managing Director - Enterprise Software
Vera Shokina
Managing Director
Peter Sletteland
Associate
Ben Tickler
Managing Director - Enterprise Software
Andrew Tsao
Managing Director. Founder / Head of Global Gateway
Jordy Samiljan
Managing Director, I Leveraged Finance and Sponsor Coverage
John Benetti
Managing Director
Past deals in Austin, TX
RenoRun
Series A in 2019
RenoRun Inc. is a construction materials delivery company that provides a wide range of products, including beams, bricks, and concrete mixes, primarily serving the construction industry. Established in 2016 and headquartered in Montreal, Canada, RenoRun operates in key markets such as Toronto, Canada, and Austin, Texas. The company offers a mobile-friendly platform that allows general contractors to efficiently order materials and receive timely deliveries directly to job sites, thereby enhancing productivity and reducing downtime. With a focus on streamlining the procurement process, RenoRun aims to be the largest single-source platform for construction materials, simplifying the supply chain for contractors and builders.
Plus Therapeutics
Post in 2013
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Austin, Texas, dedicated to the discovery, development, and manufacturing of innovative treatments for cancer and rare diseases. The company's lead product candidate, DocePLUS, is a protein-stabilized PEGylated liposomal formulation of docetaxel aimed at treating small cell lung cancer. Additionally, Plus Therapeutics is developing DoxoPLUS, a formulation of doxorubicin intended for breast and ovarian cancer, multiple myeloma, and Kaposi’s sarcoma. The company is also engaged in developing therapies for central nervous system cancers, including recurrent glioblastoma and leptomeningeal metastases, with a key candidate being rhenium (186Re) obisbemeda. Plus Therapeutics leverages proprietary nanotechnology to enhance drug delivery and efficacy while minimizing side effects. Founded in 1996, the company was previously known as Cytori Therapeutics, Inc. before rebranding in July 2019.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.